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The inositol phosphatase, MTMR4 (myotubularin-related pro-
tein 4), was identiﬁed as a novel interactor of the ubiquitin
ligase Nedd4 (neural-precursor-cell-expressed developmentally
down-regulated 4). hMTMR4 (human MTMR4) and Nedd4 co-
immunoprecipitated and co-localized to late endosomes. The PY
(Pro-Tyr) motif of hMTMR4 binds to WW (Trp-Trp) domains
of hNedd4. MTMR4 expression was decreased in atrophying
muscle, whereas Nedd4 expression was increased and hMTMR4
was ubiquitinated by hNedd4, suggesting that this novel inter-
action may underlie the biological process of muscle breakdown.
Key words: inositol phosphatase, muscle atrophy, myotubularin,
myotubularin-related protein 4(MTMR4), neural-precursor-cell–
expressed developmentally down-regulated 4 (Nedd4), ubiquitin
ligase.
INTRODUCTION
Cellular ubiquitination is a vital process regulating protein
stability, internalization and endosomal trafﬁcking [1–3]. It is a
multi-enzyme cascade whereby ubiquitin moieties are selectively
transferred on to target molecules, which, in many cases, tags
them for degradation by the 26S proteasome. Speciﬁcity, in
large part, is determined by the HECT (homologous with E6-
associated protein C-terminus)- and RING (really interesting new
gene)-type ubiquitin ligases that interact with their substrates
via speciﬁc protein–protein interaction domains. Nedd4 (neural-
precursor-cell-expressed developmentally down-regulated 4) is a
ubiquitously expressed HECT-domain-containing E3 ubiquitin–
protein ligase that has been shown to regulate the stability and/or
localization of several membrane proteins through interactions
of its WW (Trp-Trp) domain with substrate PY (Pro-Tyr) motifs
[4–9].
Nedd4 has been shown previously to increase in models of
skeletal muscle atrophy [10–12] and has been shown to target
Notch1 in skeletal muscle [11], although the mechanisms by
which Nedd4 contributes to the biological process of muscle
breakdown are unknown. We sought to identify novel protein
substrates of Nedd4 in muscle. Using a bioinformatics approach,
we identiﬁed a PY-motif-containing protein expressed in skeletal
muscle, MTMR4 (myotubularin-related protein 4), that belongs
to the family of PTPs (protein tyrosine phosphatases)/DSPs
(dual-speciﬁcity phosphatases) [13]. Myotubularins are 3
 -
phosphatases speciﬁc for PtdIns3P and PtdIns(3,5)P2. It has been
proposed that myotubularins regulate endosome trafﬁcking by
dephosphorylation of PtdIns3P [14]. Interestingly, MTMR4 is
the only family member that possesses a PY motif [15] and
has a unique distribution to endosomes [14], the major site of
substrate lipid accumulation. In the present study, we found
that MTMR4 and Nedd4 co-immunoprecipitate, interact via a
WW domain–PY motif interaction and co-localize in cells to
the PtdIns3P-rich late/recycling endosomes. Using a rat model of
denervationatrophy,wehaveconﬁrmedthattheincreaseinNedd4
expression in atrophying muscle (compared with control muscle)
iscoincidentwithadecreaseofMTMR4inatrophyingmuscle.We
demonstrate that Nedd4 ubiquitinates MTMR4 and that mutation
of the MTMR4 PY motif inhibits Nedd4 binding and MTMR4
ubiquitination, suggesting that MTMR4 is a bona ﬁde Nedd4
target. We propose that MTMR4 may play an important role in
the progression of Nedd4-mediated skeletal muscle atrophy.
EXPERIMENTAL
Cell culture
All cells were cultured at 37◦C under 5% CO2. For bio-
chemical characterization of the Nedd4–MTMR4 interaction,
plasmids expressing wild-type hNedd4 (h indicates human)
(GenBank® accession number NM_006154), catalytically
inactive hNedd4 (Cys→Ser) and human MTMR4 (accession
number NM_004687), a gift from Dr Joe Zhang (Vanderbilt-
Ingram Cancer Center, Nashville, TN, U.S.A.), either untagged
or HA (haemagglutinin)-tagged, wild-type or PY motif mutant
(whereby the second invariant proline residue of the XPPXY
motif was mutated to alanine using Stratagene QuikChange®
mutagenesis kit), were transfected into Phoenix HEK (human
embryonic kidney)-293 or HeLa cells grown in DMEM
(Dulbecco’s modiﬁed Eagle’s medium), 10% FBS (fetal bovine
serum), 100 units/ml penicillin and 100 mg/l streptomycin using
standard CaCl2 transfection. At 48 h post-transfection, cells were
harvested and lysed in lysis buffer (50 mM Hepes, pH 7.5,
150 mM NaCl, 1% Triton X-100, 10% glycerol, 1.5 mM MgCl2
Abbreviations used: BCA, bicinchoninic acid; CCD, charge-coupled device; DMEM, Dulbecco’s modiﬁed Eagle’s medium; DSP, dual-speciﬁcity
phosphatase; ENaC, epithelial sodium channel; GFP, green ﬂuorescent protein; GST, glutathione transferase; h, human; HA, haemagglutinin; HECT,
homologous with E6-associated protein C-terminus; HEK, human embryonic kidney; HPRT, hypoxanthine–guanine phosphoribosyltransferase; LAMP,
lysosome-associated membrane protein; MTMR4, myotubularin-related protein 4; Nedd4, neural-precursor-cell-expressed developmentally down-
regulated 4; PTP, protein tyrosine phosphatase; PX, phox homology domain; XLMTM, X-linked myotubular myopathy.
1 To whom correspondence should be addressed (email jane.batt@utoronto.ca).
c   The Authors Journal compilation c   2009 Biochemical Society
www.biochemj.org
B
i
o
c
h
e
m
i
c
a
l
 
J
o
u
r
n
a
l
© 2009 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.58 P. J. Plant and others
and 1 mM EGTA) vortex-mixed for 10 s and incubated on ice for
10 min. The lysate was then cleared by centrifugation at 12000 g
for 10 min, and the protein concentrations in the supernatant were
quantiﬁed using BCA (bicinchoninic acid) protein assay (Pierce).
Immunoprecipitation and Western blotting
For co-immunoprecipitation of MTMR4 and Nedd4, equal
amounts of lysate from hMTMR4 or HA–hMTMR4 wild-type or
PYmutanttransfectedoruntransfectedHeLacellswereincubated
with 2 μg of anti-MTMR4 or anti-Nedd4 antibodies for 1 h on
ice. Then, 50 μl of Protein A–Sepharose beads (50% slurry) was
added to the lysate and incubated for 1 h at 4◦C while spinning.
Beads were then precipitated by centrifugation at 10000 g for
1m i n a t 4◦C and washed twice in high-salt HNTG buffer
(500 mM NaCl, 20 mM Hepes, pH 7.5, 10% glycerol and 0.1%
Triton X-100) and three times in low-salt HNTG buffer (150 mM
NaCl, 20 mM Hepes, pH 7.5, 10% glycerol and 0.1% Triton
X-100). The beads were mixed with 45 μlo f1 × Sample Buffer
and boiled at 95◦C for 5 min to elute proteins. Protein eluate was
resolved by SDS/8% PAGE and transferred on to Protran 0.2 μm
pore-size nitrocellulose membranes (PerkinElmer).
Western blotting was performed using the following primary
antibodies: polyclonal anti-Nedd4 WW2 antibodies (Upstate
Biotechnology), 1:1000 dilution; polyclonal anti-MTMR4 anti-
bodies (Abgent), 1:200 dilution; monoclonal anti-α-tubulin
antibodies (Sigma–Aldrich), 1:10000 dilution; monoclonal
anti-HA antibodies (Covance), 1:1000 dilution; monoclonal anti-
ubiquitin antibodies (Covance), 1:1000 dilution and polyclonal
anti-HPRT (hypoxanthine–guanine phosphoribosyltransferase)
antibodies(Abcam),1:1000dilution.Proteinbandsweredetected
withhorseradish-peroxidase-linkedgoatanti-rabbitoranti-mouse
secondary antibodies (Cell Signaling Technology) used at a
1:20000 dilution.
Immunostaining
HeLa cells grown in DMEM were plated on coverslips. After
24 h, cells were transfected as indicated using FuGene
TM 6
reagent (Hoffmann-La Roche). After a further 24 h, cells were
ﬁxed in 3.7% (w/v) paraformaldehyde, permeabilized in 0.2%
Triton X-100 and blocked in 10% (w/v) non-fat dried skimmed
milk powder in PBS. Primary antibodies were incubated for 1 h
at room temperature (20◦C), and then were washed in PBS.
Secondary antibodies conjugated to ﬂuorophores were added
for 45 min and washed, and coverslips were mounted on slides
in Vectashield mounting medium (Vector Laboratories). Images
were acquired using a spinning-disc confocal microscope (Zeiss)
and Volocity software (Improvision, PerkinElmer). Primary
antibodies used were: mouse anti-GM130 (BD Biosciences),
mouse anti-LAMP-1 (lysosome-associated membrane protein 1)
(Developmental Studies Hybridoma Bank, University of Iowa,
Iowa City, IA, U.S.A.), mouse anti-(transferrin receptor)
(Zymed Laboratories) and mouse anti-HA (Covance). Secondary
antibodies used were Cy3 (indocarbocyanine)-conjugated anti-
mouse and Cy2 (carbocyanine)-conjugated anti-mouse (Jackson
ImmunoResearch Laboratories). In addition to HA-tagged
MTMR4, some cells were transfected with either GFP (green
ﬂuorescent protein)-tagged Rab5, GFP-tagged Rab7, PX (phox
homology domain)–mCherry (gifts from Dr Sergio Grinstein,
Hospital for Sick Children, Toronto, Ontario, Canada) and/or
GFP–hNedd4. For quantiﬁcation of co-localization, images were
analysed with the Volocity software co-localization feature
that calculates measurement statistics including the Manders
correlation coefﬁcient.
In vitro binding assays
Human Nedd4-1 WW domains in pQE-30 (Qiagen) were a gift
from Daniela Rotin (Hospital for Sick Children, Toronto). The
WW domains were cloned with the following boundaries: WW
I, 638–760 bp; WW II, 1112–1231 bp; WW III, 1318–1425 bp;
WW IV, 1487–1606 bp. His6-tagged proteins were produced in
M15 [pREP4] Escherichia coli bacteria and puriﬁed following
the manufacturer’s instructions (Qiagen). GST (glutathione
transferase)-fusion proteins of hMTMR4 were produced by
PCR of the PY-motif-containing region (2965–3081 bp) and a
proline-rich region (1972–2091 bp), TA cloning into pCR2.1-
TOPO (Invitrogen), subsequent cloning into pGEX-5X1 and
expression in BL21(DE3) pLysS E. coli bacteria according
to the manufacturer’s protocol (Promega). GST-fusion proteins
were bound on glutathione–agarose beads (50% slurry) by
incubating for 1 h at 4◦C. Proteins were eluted with 30 mM
reduced glutathione by incubating for 1 h at 4◦C. Eluted GST-
fusion proteins and His6-bound proteins were quantiﬁed, and
equal amounts of GST-fusion proteins of regions of hMTMR4
encompassing the PY motif (GST–PY) or a proline-rich region
N-terminal to the PY motif (GST–Pro) were incubated with equal
amounts of His6-bound proteins for 2 h at 4◦C. The beads and
bound proteins were washed three times with high-salt HNTG
buffer (as above) and twice with low-salt HNTG buffer. Beads
were then mixed with 20 μlo f1 × sample buffer and boiled at
95◦C for 5 min to elute proteins. The protein eluate was resolved
by SDS/15% PAGE and transferred on to Protran 0.2 μm pore-
size nitrocellulose and subjected to Western blotting with anti-
His5 (Qiagen) and anti-GST antibodies (Sigma).
Experimental denervation model and muscle preparation
The model of muscle breakdown/atrophy was the gastrocnemius
muscle denervation model described previously [16,17]. Brieﬂy,
the right tibial nerve of 18 male Lewis rats (200 g each) was
transected under inhalational halothane anaesthesia completely
denervating the gastrocnemius muscle. The contralateral leg
servedasaninternalcontrolineachanimal.Ratsweremaintained
under conditions of routine care for 30 days, after which they
were killed, and the gastrocnemius muscles were harvested from
the operated experimental limb and non-operated control limb.
All procedures involving animals were carried out in accordance
with the Canadian Council on Animal Care guidelines and were
approved by the Animal Research Ethics Board of McMaster
University. After rapid atraumatic dissection, the muscle was
snap-frozen in liquid nitrogen. Half of the muscle was used
for total RNA isolation, and the other half was used to extract
soluble and insoluble cellular protein. Total protein was extracted
by homogenizing (Polytron PT 1200E, Kinematica) the muscle
in muscle lysis buffer (5 mM Tris/HCl, pH 8.0, 1 mM EDTA,
1 mM EGTA, 1 mM 2-mercaptoethanol, 1% glycerol, 1 mM
PMSF, 10 μg/ml leupeptin and 10 μg/ml aprotinin) three times
for 30 s, and homogenates were centrifuged at 1600 g for 10 min
at 4◦C. The supernatant (soluble fraction) was centrifuged further
at 10000 g for 10 min at 4◦C. The pellet (insoluble fraction) was
washedwithPBS,resuspended,dissolvedbysonicationin200 μl
of muscle lysis buffer containing 0.5% SDS and centrifuged
further at 10000 g for 10 min at 4◦C, and the supernatant was
designated as the insoluble fraction. All fractions were quantiﬁed
using BCA protein assay and normalized for equal loading.
Then, 25 μg of the muscle lysate was separated by SDS/8%
PAGE, and Western blotting was performed using anti-MTMR4,
anti-Nedd4 and anti-HPRT antibodies. The chemiluminescence
signalwasacquiredusingaCCD(charge-coupleddevice)camera
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(Bio-Rad Laboratories Fluor-S Max), and the total signal was
quantiﬁed using Quantity One software (Bio-Rad Laboratories)
with volume analysis.
Statistical analyses
Continuousdataarereportedasamean+ −S.D.andwerecompared
using ANOVA, followed by Tukey’s post-analysis to compare
multiple means if P<0.05 (statistical signiﬁcance).
RESULTS
MTMR4 is a PY-motif-containing protein expressed in muscle that
interacts with Nedd4
As Nedd4 overexpression was correlated with the progression of
atrophic processes in muscle cells, we sought potential substrates
in muscle that may be targeted by Nedd4 to elicit its effects.
To this end, we took a bioinformatics approach to elucidate
PY-motif-containing proteins that were expressed in skeletal
muscle. Nedd4 consists of an N-terminal C2 domain, three or
four WW domains and the ubiquitin ligase HECT domain and,
in many cases, engages in interactions with its substrates via a
WW domain–PY motif interaction [4–9]. Searching a SIDNET
(Signalling Identiﬁcation Network) MGC (Mammalian Gene
Collection) clone database (http://www.sickkids.ca/Research/
SIDNET/SIDNET.html) for PY-motif-containing proteins that
were expressed in skeletal muscle limited potential substrates of
Nedd4 to several proteins, including MTMR4, which belongs
to a family of lipid tyrosine phosphatases with speciﬁcity
towards PtdIns3P and PtdIns(3,5)P2 [14,15]. MTMR4 possesses
several protein–protein and protein–lipid interaction domains
(Figure 1A) including the FYVE domain, shown to mediate its
localization to endosomes through its interaction with PtdIns3P
and PtdIns(3,5)P2 [14] and is the only family member possessing
a PY motif. The MTMR4 PY-motif (VPPLY) at the C-
terminus (positions 1004–1008) is conserved across mammalian
species (results not shown), adhering to the canonical L/XPPXY
consensus sequence for WW domain type I binding. To verify
that Nedd4 and MTMR4 can interact, cDNA for hMTMR4
was transfected into HEK-293 cells, and lysate from these
cells was subjected to immunoprecipitation with anti-MTMR4
antibodies. Immunoprecipitates were separated by SDS/PAGE
and probed with anti-MTMR4 and anti-Nedd4 antibodies to
determine whether the two proteins interacted, with anti-tubulin
antibodies used as a control. Immunoprecipitated transfected
hMTMR4 interacted with endogenous Nedd4, but no band was
detected in untransfected lysate (Figure 1B). Similarly, cell
lysate transfected with HA-tagged hMTMR4 wild-type and PY-
motif mutant was immunoprecipitated with anti-Nedd4 anti-
bodies, and subjected to Western blotting with anti-Nedd4,
anti-HAandanti-tubulinantibodies.EndogenousNedd4wasable
toimmunoprecipitatetransfectedwild-typehMTMR4,butnotthe
MTMR4 PY mutant, suggesting that the endogenous association
of the two proteins is likely to be mediated through the WW
domain–PY motif interaction (Figure 1C).
Nedd4 and MTMR4 co-localize in cells
Previous studies have found that MTMR4 has unique distribution
to endocytic compartments [14]. We examined co-localization of
transfected hMTMR4 and hNedd4 in HeLa cells. In a represent-
ative image, the two proteins show a striking overlap with a
punctate distribution (Figure 2A). Examination and counting of
cells in 14 ﬁelds of view at 63× magniﬁcation showed that
Figure1 MTMR4isaPY-motif-containingproteinexpressedinmusclethat
interacts with Nedd4
(A)SchematicdiagramofhumanMTMR4,basedon[33].ProteindomainspredictedwithSMART
(http://smart.embl-heidelberg.de/) and PFSCAN (http://hits.isb-sib.ch/cgi-bin/PFSCAN)
include GRAM (glucosyltransferase, Rab-like GTPase activator of myotubularins) domain, RID
(Rac-induced recruitment domain), PTP/DSP domain, SID (SET-interacting domain), PY motif
(XPPXY),CC(coiled-coil)domainandFYVEdomain.(B)WesternblotofhMTMR4,Nedd4and
tubulin from transfected (MTM tx) or untransfected (untx) HEK-293 lysate immunoprecipitated
with anti-MTMR4 antibodies (MTM I.P.). Equal amounts of whole lysate were run as a control.
(C) Lysates (lysate) and immunoprecipitates using anti-Nedd4 antibodies (Nedd4 I.P.) or
anti-(p70 S6 kinase) antibodies (p70 S6 I.P.) as negative control, of HeLa cells transfected
with HA–hMTMR4 wild-type (MTM WT), HA–hMTMR4 PY mutant (MTM PY), pcDNA 3.1
vector alone (vec) or untransfected (untx). Immunoblotting (IB) was performed with anti-HA
(monoclonal)antibodiesfollowedbyanti-Nedd4(polyclonal)antibodiesandblotswerestripped
and re-probed with anti-tubulin antibodies as control. Molecular masses are indicated in kDa.
Nedd4 and MTMR4 co-localized in 72% of cells that were co-
expressing both transfected proteins. Quantitative analysis of
co-localization yielded high Mander’s correlation coefﬁcients,
indicative of signiﬁcant overlap of the Nedd4 and MTMR4
signal [r(20)=0.93, with r(n) being Mander’s co-localization
coefﬁcientforndegreesoffreedom,P<0.05].Toverifythatthese
punctaeareendosomalinnature,weexaminedtheco-localization
of hMTMR4 in HeLa cells with several markers of early, late and
recycling endosomes, as well as Golgi and lysosomal markers
(Figure 2B). No co-localization was observed of hMTMR4
and the early endosomal marker Rab5 [r(13)=0.19], nor was
there signiﬁcant overlap in MTMR4 signal with the lysosomal
marker LAMP [r(9)=0.16] or the Golgi marker GM130 (cis-
Golgi matrix protein of 130 kDa) [r(8)=0.09] (results not
shown). There was signiﬁcant overlap between MTMR4 and
Rab7/transferrin (Figure 2B), indicative of localization to late
and recycling endosomes, an impression that was validated
quantitatively [r(10)=0.81, P<0.05 and r(13)=0.78, P<0.05
respectively]. Since PtdIns3P is a major lipid substrate of
MTMR4, we co-transfected hMTMR4, GFP–hNedd4 and PX–
mCherry (the PX domain of NADPH oxidase binds to PtdIns3P
with high speciﬁcity [18]) to determine localization. hMTMR4
and hNedd4 co-localized speciﬁcally to areas of PX (PtdIns3P)
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Figure 2 MTMR4 and Nedd4 co-localize to late endosomes/recycling
endosomes in living cells
(A) Immunoﬂuorescence of HeLa cells transfected with HA-tagged hMTMR4 (red) and
GFP–hNedd4 (green). Overlay shows merging of the two images. (B) Co-localization of
HA–hMTMR4 with markers of late endosomes (Rab7) and recycling endosomes (transferrin
receptor). HA–hMTMR4 does not co-localize with markers of early endosomes (Rab5).
(C) Triple labelling of HeLa cells transfected with HA–hMTMR4 (blue), GFP–Nedd4 (green)
and PX–mCherry (red) to represent PtdIns3P localization. Arrowheads point to examples of
co-localization.Mander’sco-localizationcoefﬁcients,r (degreesoffreedom),areshownforeach
set of co-staining. Scale bars, 11μm.
staining (Figure 2C) consistent with endosomal localization
[r(10)=0.85, P<0.05 and r(8)=0.91, P<0.05 respectively].
Nedd4 and MTMR4 interact via a WW domain-PY motif interaction
To verify that the interaction between the two proteins was
mediated by a WW domain–PY motif interaction, we expressed
His6-tagged versions of the four WW domains of human Nedd4
and incubated equal amounts of the fusion proteins (on Ni
2+
beads) with GST–PY and GST–Pro as a control. We found that
GST–PYconsistentlyboundtoWWIIIandIVofhNedd4(n=3),
but GST–Pro did not bind to any of the His6–WW fusion proteins
(Figure 3), verifying that the interaction between hMTMR4 and
hNedd4ismediatedthroughaPYmotif–WWdomaininteraction.
This ﬁnding with MTMR4 is consistent with other substrates of
Nedd4, as hNedd4 WW IV corresponds to the high-afﬁnity WW
Figure 3 MTMR4 and Nedd4 binding is mediated through a PY motif–WW
domain interaction
GST-fusionproteinsoftheareaencompassingthePYmotifofhMTMR4(GST-hMTMR4PY)and
of a non-PY-containing proline-rich region of hMTMR4 (GST-hMTMR4 PRO) as control were
generated in bacteria as described in the Experimental section. Samples of 0.3μg of soluble
and GST–PY and GST–Pro were incubated with 0.5μgo fH i s 6-tagged hNedd4–WWI, –WWII,
–WWIII or –WWIV immobilized on Ni2+-nitrilotriacetate beads (His-hNedd4 WW domain I–IV)
orHis6–beadsalone(His).Followingthoroughwashesofthebeads,boundproteinswereeluted
withsamplebuffer,separatedbySDS/PAGE,andWesternblottingwasperformedwithanti-GST
and anti-His antibodies. Molecular masses are indicated in kDa.
III in rat, which was found to bind to the PY motif of a subunit of
the epithelial sodium channel, ENaC [19]. Mutation or deletion
of the ENaC PY motif obliterates Nedd4 binding, resulting in
Liddle’s syndrome [19].
Nedd4 protein is increased in muscle atrophy
As we, and others, have shown that Nedd4 expression increases
upon denervation induced atrophy [10,11], we hypothesized
that any potential targets of Nedd4-mediated ubiquitination
(and subsequent degradation) would be decreased. To determine
whether MTMR4 protein levels are affected by denervation-
induced atrophy, we performed Western blot analysis of protein
lysate from experimental (denervated atrophied muscle) and
control (contralateral innervated rat muscle) with anti-MTMR4
antibodies. We found that the antibody recognized several bands
of different size (results not shown); many were differentially
expressed in experimental compared with control limbs. The
HEK-293 cell lysate, transfected with hMTMR4 cDNA, was run
alongside the control and experimental insoluble muscle lysates
to conﬁrm the identity of MTMR4 in these fractions. A faint band
(approx.160 kDa)wasrecognizedbytheanti-MTMR4antibodies
in the control lysate, corresponding to what has been reported in
previous studies with hMTMR4 [15] (Figure 4A). The intensity
of the band decreased in the experimental (denervated) lysate
compared with the control, whereas Nedd4 expression increased
in the denervated muscle lysates compared with the control.
The expression of HPRT remained unchanged. Quantiﬁcation
of the blots with CCD acquisition of the chemiluminescence
signal shows that MTMR4 decreases approx. 90% with a 2-fold
increase in Nedd4 expression (Figure 4B). These data suggest
that decreased levels of MTMR4 protein correlate with increased
levels of Nedd4 protein, supporting the notion of MTMR4 being
a target of Nedd4-mediated degradation.
MTMR4 ubiquitination is dependent on an intact PY motif
MTMR4 co-precipitates with Nedd4 and has a differential
expression pattern in muscle compared with that of Nedd4, so
we hypothesized that it is a potential substrate for ubiquitination
anddegradationbyNedd4.Conjugationofubiquitinmoietiestags
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Figure 4 MTMR4 and Nedd4 are differentially regulated in atrophied muscle
(A) Representative Western blot of MTMR4, Nedd4 and HPRT (as loading control) from gastrocnemius muscle insoluble protein fractions from denervated (Den) and contralateral control (Con)
limbs. MTM tx is positive control lysate from MTMR4 transfected or untransfected (untx) HEK-293 cells. Molecular masses are indicated in kDa. (B) Quantiﬁcation of the chemiluminescent signal
from Western blots performed using Bio-Rad Fluor-S Max acquisition system and Quantity One software. Each bar represents the results from eight muscles (mean+S.E.M.). P <0.05 denotes
statistically signiﬁcant differences between mean values. CNT, counts.
proteins for degradation by the proteasome, so we rationalized
that, if MTMR4 was a bona ﬁde target for degradation by
Nedd4, then Nedd4 would ubiquitinate MTMR4. Mutation of
the MTMR4 PY motif prevents Nedd4 binding and thus would
spare the mutant MTMR4 from ubiquitination and subsequent
degradation. Cellular lysates from HeLa cells transfected with
HA-tagged hMTMR4, HA-tagged PY mutant hMTMR4 (both
transfected together with hNedd4) or untransfected lysate were
subjected to immunoprecipitation with anti-MTMR4 antibodies
(Figure5).ImmunoprecipitateswereseparatedbySDS/PAGEand
probed with anti-ubiquitin, anti-HA and anti-Nedd4 antibodies
to detect the expression of the proteins. Ubiquitinated MTMR4
(seen as a high-molecular-mass smear) was detected in
immunoprecipitates only when wild-type MTMR4 was trans-
fected, but not in immunoprecipitates from the PY-mutant-
transfected or untransfected lysate (Figure 5). These data suggest
that the MTMR4 PY motif is necessary for Nedd4 interaction and
subsequent ubiquitination [20].
DISCUSSION
In the present paper, we describe a novel interaction between
the ubiquitin ligase Nedd4 and the DSP MTMR4, a regulator
of phosphoinositide metabolism and thus of endosomal function.
Although this interaction has not been previously identiﬁed, it is
not unexpected, as previous studies have shown an association of
Nedd4withphosphoinositidesandaninvolvementinendocytosis.
The N-terminal C2 lipid-binding domain of Nedd4 has been
shown to mediate Ca
2+-dependent phospholipid binding and
membrane association [21], in addition to mediating its own
protein–protein interactions that serve to localize it to apical rafts
[22]. The Nedd4 C2 domain displayed no preferences towards
lipid composition in an in vitro binding assay, but was shown to
bind phosphoinositides, and this binding was partially augmented
in the presence of Ca
2+. In addition, the yeast Nedd4 homologue,
Rsp5, has a well-deﬁned role in endocytosis; the C2 domain
of Rsp5 localizes it to the plasma membrane, where Rsp5 binds
membrane phosphoinositides directly and directs ubiquitination
of endosomal cargo [23–25].
Little is known of the regulation and physiological role
of MTMR4, but studies show a unique distribution to endo-
somal structures, the major site of substrate lipid (PtdIns3P)
accumulation [14]. In the present study, we have shown that
MTMR4 co-localizes with the late endosomal marker Rab7
in addition to the transferrin receptor, a marker for recycling
endosomes. In addition, MTMR4 and Nedd4 both localize to
areas of PtdIns3P staining, all suggesting that MTMR4 and
Nedd4 are co-localized to late endosomes. Phosphatase-inactive
forms of MTMR4 or overexpression of wild-type MTMR4
were shown to inhibit EGFR (epidermal growth factor receptor)
degradation[14].ThiseffectwasabrogatediftheMTMR4FYVE
domain was mutated, and was recapitulated by the expression
of the FYVE domain alone at very high levels, promoting the
notion that this family member mediates endosomal trafﬁcking
by engaging in speciﬁc interactions between its FYVE domain
and endosomal phosphoinositides, thus affecting the balance of
PtdIns3P synthesis and degradation.
Mutations in other MTM family members are associated
with muscle dysfunction. This is not unexpected, since muscle
is the predominant location of MTM expression. In humans,
MTM1 mutations are associated with XLMTM (X-linked myotu-
bular myopathy), which is a congenital myopathy associated
with major hypotonia at birth [26,27]. The histopathology of
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Figure 5 MTMR4 ubiquitination is dependent on an intact PY motif
(A) HeLa cell lysate transfected with HA-tagged hMTMR4 or HA-tagged hMTMR4 PY motif mutant, together with hNedd4 or untransfected lysate (untx) were subjected to immunoprecipitation (I.P.)
with anti-MTMR4 antibodies. Beads were washed and separated by SDS/PAGE with total lysate and then subjected to Western blotting with anti-ubiquitin (Ub) antibodies to detect ubiquitinated
MTMR4. Blots were re-probed with anti-HA antibodies to detect transfected hMTMR4 and then stripped and re-probed with anti-Nedd4 antibodies to detect transfected Nedd4. Aliquots of whole-cell
lysate were subjected to immunoblotting with anti-HA and anti-Nedd4 antibodies. Blots were stripped and re-probed with anti-α-tubulin antibodies as a loading control. Ubiquitinated MTMR4 is
seen as a high-molecular-mass smear (top-left-hand panel) in the hMTMR4 transfected lysate only. Molecular masses are indicated in kDa.
skeletal muscle reveals small rounded ﬁbres with central nuclei.
Mtm1-knockout mice recapitulate the histological signs of
XLMTM and show a progressive myopathy starting at a few
weeks after birth, whereas muscle histology appears normal at
birth [26]. Adenoviral-mediated replacement of MTM1 reverses
themyopathycompletely,restoringmusclemassandcontractility
[28]. This suggests that the defect in the muscle ﬁbres is due
to a defect in structural maintenance rather than an impairment
of myogenesis, as was hypothesized previously. Furthermore,
knockdown of Caenorhabditis elegans MTMR3, the closest
relative of MTMR4 and the only other family member to contain
a FYVE domain,results in severeimpairment of bodymovement,
revealing a critical role for MTMR3 in maintaining muscle
function [29]. In the present study, the ﬁnding that increased
levels of Nedd4 in atrophied muscle correlate with a decrease
in the levels of MTMR4 supports the notion of MTM family
regulation of muscle structure and function.
TheroleoftheNedd4–MTMR4interactioninthephysiological
progression of muscle atrophy can be speculated upon. Phospho-
inositidesareimportantmembranelipidsthatregulatecellgrowth
and survival, cell division and membrane trafﬁcking through
recruiting and activating effector proteins and enzymes that
contain phosphoinositide-binding domains, to speciﬁc membrane
microdomains [30]. The MTM substrate PtdIns3P,w h i c hi s
highly enriched in early endosomes and internal vesicles of
multivesicular endosomes late in the endosome pathway, plays
a major role in endocytic trafﬁcking [30,31]. Depletion of
PtdIns3P results in inefﬁcient sorting and delayed trafﬁcking
of a number of proteins (such as internalized growth factor
receptors) through the endocytic pathways to the late endosome
and lysosome. A main function of the other MTM substrate,
PtdIns(3,5)P2, is to catalyse the budding of vesicles from the late
endosome as yeast mutations in Fab1p/PIKfyve kinase [the
enzyme that phosphorylates PtdIns3P to PtdIns(3,5)P2] results
in enlarged poorly acidiﬁed vacuoles and late endosomes [32].
Thus decreased levels of MTM expression, or alternatively MTM
loss-of-function mutants, probably result in cellular dysfunction
because of inadequate dephosphorylation of PtdIns3P and
PtdIns(3,5)P2 and dysregulation of the lipid signaling within the
endocytic pathway. Experimental models examining the status
of endosomal trafﬁcking and receptor recycling in the absence of
MTMR4 and/or mutants that are defective in its ubiquitination
can address the contribution of Nedd4 to these processes and
the participation of endosomal trafﬁcking to the progression of
muscle atrophy.
In conclusion, we have identiﬁed a novel Nedd4 target in
muscle, the inositol phosphatase MTMR4, which implicates
further a role for Nedd4 in regulating endosomal signalling
and distinguishes a candidate for future studies examining the
physiological role of Nedd4 action in atrophying muscle.
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